Medicine Related News
Vektor Pharma: leaders in thin film drug formulations
Vektor Pharma TF GmbH and its team have been leaders in the design, testing, and manufacture of thin film drug formulations.
Vektor Pharma TF GmbH ...
Antibiotic-resistant infections have fallen for the first time since 2016
New data by the UK Health Security Agency (UKHSA) shows that antibiotic-resistant bloodstream infections fell in 2020, from 65,583 in 2019 to 55,384. However,...
Positive opinion for hereditary angioedema medicine for use in patients over 12
The Committee for Medicinal Products for Human Use (CHMP) has recommended the medicine berotralstat for the routine prophylaxis of hereditary angioedema in patients aged...
New pathway for approval of medicines in the UK
A new pathway for the approval of medicines in the UK has opened, aiming to bring closer collaboration between authorities and bodies and helping...
UK’s first investment fund dedicated to psychedelic healthcare
In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched.
The new fund comes as recent rigorous clinical trials...
UK medicine manufacturing to receive funding boost
Funding of £20m will be provided to improve medicine supply chains in the UK and help to create thousands of new jobs.
The money, which...
European Commission approves epilepsy medicine to treat children
The European Commission has approved expanding the indication of anti-epileptic agent Fycompa to include the treatment of children with epilepsy.
The European Commission (EC) has...
MHRA to review acne treatment isotretinoin and suspected links with psychiatric and sexual side...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a call for information on isotretinoin, a treatment for severe acne, which has been...
Early access to medicine for hereditary angioedema patients
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive scientific opinion to the medicine berotralstat for hereditary angioedema patients through...
Drug combination shows promise for treating COVID-19
New findings have shown that a triple antiviral drug combination holds promise for the treatment of COVID-19.
Results from a randomised trial for treating COVID-19...
The evolution of the American cannabis industry in the last decade
The American cannabis industry squinted into daylight as it emerged into a billion-dollar industry coming from a black market background. Since then, it is...
Medical cannabis prescriptions: three years of cannabis law in Germany
Since the introduction of the cannabis law in Germany in 2017, healthcare provider, the BARMER, will have received 14,986 applications for medical cannabis products...
Cannabis and integrative medicine in Canada
Dr Dani Gordon, double board-certified medical doctor speaks to Health Europa Quarterly about her journey in the medical cannabis industry and how it fits...
A new way of thinking: teaching clinicians and patients about cannabis
Cannabis is disrupting the way we look at medicines – but more people need to be educated about cannabis before it becomes commonly accepted...
Painkiller alternative: is turmeric the answer for arthritis?
New research highlights that arthritis sufferers are looking for alternatives to painkillers and turmeric could be the answer
There are nearly ten million brits that...
Partnership for new drugs derived from cannabis to prevent vision loss
A new partnership has been formed to license two new synthetic drug candidate formulations derived from cannabis.
The cannabis research program at the University of...
Breakthrough research offers new hope to lupus patients
A ‘life-changing’ potential new drug could be available to lupus patients in the future thanks to ‘breakthrough’ research.
The results of the TULIP II study...
Fungi: a kingdom to address the antimicrobial resistance problem
A report by the OECD in 2015 estimated that we can expect an average of 10 million human deaths per year between 2015 and...
Cannadabis: tissue culture and the future of cannabis cultivation
Cannadabis Medical INC is dedicated to the organic and holistic production of cannabis medicine and related technology.
Cannadabis Medical INC they intend to create a...
Canngea’s mission to halt the global medicine shortage of cannabis
Currently, the supply of medical cannabis is not meeting the global demand, but could Canngea change this?
One company is aiming to put a halt...
